Revvity Total Liabilities 2010-2024 | RVTY
- Revvity total liabilities for the quarter ending September 30, 2024 were $4.848B, a 15.35% decline year-over-year.
- Revvity total liabilities for 2023 were $5.692B, a 15.64% decline from 2022.
- Revvity total liabilities for 2022 were $6.747B, a 14.15% decline from 2021.
- Revvity total liabilities for 2021 were $7.859B, a 86.03% increase from 2020.
Revvity Annual Total Liabilities (Millions of US $) |
|
---|---|
2023 | $5,692 |
2022 | $6,747 |
2021 | $7,859 |
2020 | $4,225 |
2019 | $3,725 |
2018 | $3,391 |
2017 | $3,588 |
2016 | $2,123 |
2015 | $2,056 |
2014 | $2,085 |
2013 | $1,952 |
2012 | $1,962 |
2011 | $2,013 |
2010 | $1,284 |
2009 | $1,430 |
Revvity Quarterly Total Liabilities (Millions of US $) |
|
---|---|
2024-09-30 | $4,848 |
2024-06-30 | $5,555 |
2024-03-31 | $5,586 |
2023-12-31 | $5,692 |
2023-09-30 | $5,727 |
2023-06-30 | $6,349 |
2023-03-31 | $6,604 |
2022-12-31 | $6,747 |
2022-09-30 | $6,759 |
2022-06-30 | $7,023 |
2022-03-31 | $7,662 |
2021-12-31 | $7,859 |
2021-09-30 | $7,941 |
2021-06-30 | $4,500 |
2021-03-31 | $4,760 |
2020-12-31 | $4,225 |
2020-09-30 | $3,634 |
2020-06-30 | $3,669 |
2020-03-31 | $3,625 |
2019-12-31 | $3,725 |
2019-09-30 | $3,782 |
2019-06-30 | $3,692 |
2019-03-31 | $3,448 |
2018-12-31 | $3,391 |
2018-09-30 | $3,290 |
2018-06-30 | $3,441 |
2018-03-31 | $3,571 |
2017-12-31 | $3,588 |
2017-09-30 | $2,203 |
2017-06-30 | $2,166 |
2017-03-31 | $2,132 |
2016-12-31 | $2,123 |
2016-09-30 | $2,169 |
2016-06-30 | $2,106 |
2016-03-31 | $2,161 |
2015-12-31 | $2,056 |
2015-09-30 | $1,977 |
2015-06-30 | $1,962 |
2015-03-31 | $1,968 |
2014-12-31 | $2,085 |
2014-09-30 | $1,824 |
2014-06-30 | $1,881 |
2014-03-31 | $1,942 |
2013-12-31 | $1,952 |
2013-09-30 | $1,932 |
2013-06-30 | $1,951 |
2013-03-31 | $1,974 |
2012-12-31 | $1,962 |
2012-09-30 | $1,948 |
2012-06-30 | $1,916 |
2012-03-31 | $1,982 |
2011-12-31 | $2,013 |
2011-09-30 | $1,457 |
2011-06-30 | $1,639 |
2011-03-31 | $1,398 |
2010-12-31 | $1,284 |
2010-09-30 | $1,541 |
2010-06-30 | $1,502 |
2010-03-31 | $1,396 |
2009-12-31 | $1,430 |
2009-09-30 | $1,457 |
2009-06-30 | $1,372 |
2009-03-31 | $1,346 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $13.453B | $2.751B |
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $84.995B | 10.55 |
Cencora (COR) | United States | $43.734B | 16.44 |
DiDi Global (DIDIY) | China | $22.941B | 0.00 |
Natera (NTRA) | United States | $20.871B | 0.00 |
ICON (ICLR) | Ireland | $16.879B | 15.03 |
Viatris (VTRS) | United States | $14.478B | 4.46 |
Avantor (AVTR) | United States | $14.307B | 21.45 |
BioMerieux (BMXMF) | France | $12.659B | 0.00 |
CochLear (CHEOY) | Australia | $11.807B | 0.00 |
Solventum (SOLV) | United States | $11.540B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.417B | 29.35 |
Doximity (DOCS) | United States | $10.302B | 60.64 |
Charles River Laboratories (CRL) | United States | $9.314B | 18.00 |
HealthEquity (HQY) | United States | $8.212B | 41.20 |
Sonic Healthcare (SKHHY) | Australia | $8.208B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $6.322B | 29.43 |
Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
Sotera Health (SHC) | United States | $3.759B | 20.11 |
Organon (OGN) | United States | $3.719B | 3.75 |
BrightSpring Health Services (BTSG) | United States | $2.967B | 63.11 |
Surgery Partners (SGRY) | United States | $2.493B | 28.42 |
Concentras Parent (CON) | United States | $2.491B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.291B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.069B | 0.00 |
Premier (PINC) | United States | $2.067B | 10.76 |
PACS (PACS) | United States | $1.992B | 0.00 |
Alignment Healthcare (ALHC) | United States | $1.969B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.730B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.711B | 44.90 |
Teladoc Health (TDOC) | United States | $1.544B | 0.00 |
Pediatrix Medical (MD) | United States | $1.224B | 11.98 |
Progyny (PGNY) | United States | $1.208B | 24.47 |
Embecta (EMBC) | United States | $1.161B | 8.12 |
CareDx (CDNA) | United States | $1.102B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.090B | 0.00 | |
AMN Healthcare Services Inc (AMN) | United States | $0.874B | 5.91 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
Agilon Health (AGL) | United States | $0.775B | 0.00 |
SBC Medicals (SBC) | United States | $0.649B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.492B | 0.00 |
InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
DocGo (DCGO) | United States | $0.444B | 16.73 |
Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
Enhabit (EHAB) | United States | $0.387B | 33.48 |
Sera Prognostics (SERA) | United States | $0.275B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.268B | 0.00 |
LifeMD (LFMD) | United States | $0.212B | 0.00 |
Biodesix (BDSX) | United States | $0.198B | 0.00 |
Beauty Health (SKIN) | United States | $0.176B | 0.00 |
Nutex Health (NUTX) | United States | $0.160B | 0.00 |
ModivCare (MODV) | United States | $0.156B | 8.44 |
MultiPlan (MPLN) | United States | $0.108B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.099B | 0.00 |
So-Young (SY) | China | $0.093B | 15.69 |
IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
OncoCyte (OCX) | United States | $0.037B | 0.00 |
NeueHealth (NEUE) | United States | $0.033B | 0.87 |
Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
Oncology Institute (TOI) | United States | $0.016B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
KindlyMD (KDLY) | United States | $0.007B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |
Aclarion (ACON) | United States | $0.001B | 0.00 |